About Us
Company Overview
Vision / Mission / Values
Leadership
Clinical Advisory Board
Partnering
Our Approach
Technologies
Manufacturing
Publications
Pipeline
Pipeline
CAR T-cell therapies
mAb
Expanded Access
Investors
Announcements
Corporate Governance
Corporate Deck & Presentations
Webcasts
Presentations
Financial Reports
Listing Documents
IR Contact
Newsroom
Careers
Join Us
Contact Us
EN
简
About Us
Company Overview
Vision / Mission / Values
Leadership
Clinical Advisory Board
Partnering
Our Approach
Technologies
Manufacturing
Publications
Pipeline
Pipeline
CAR T-cell therapies
mAb
Expanded Access
Investors
Announcements
Corporate Governance
Corporate Deck & Presentations
Webcasts
Presentations
Financial Reports
Listing Documents
IR Contact
Newsroom
Careers
Join Us
Contact Us
Newsroom
Home
-
Newsroom
-
Search News
01
Mar 2024
NMPA Approves the NDA for CARsgen's BCMA CAR-T Therapy Zevorcabtagene Autoleucel for Relapsed or Refractory Multiple Myeloma
Mar 01, 2024
19
Jan 2024
CARsgen’s Presents Updated Research Results on CT041 at 2024 ASCO GI Meeting
Jan 19, 2024
15
Jan 2024
CARsgen’s CT011 achieves IND clearance from the NMPA for the GPC3-positive stage Ⅲa hepatocellular carcinoma at high risk of recurrence after surgical resection
Jan 15, 2024
12
Dec 2023
CARsgen Presents Updated Research Results on Zevor-cel at 2023 ASH Annual Meeting
Dec 12, 2023
04
Dec 2023
CARsgen’s CT071 Received IND Clearance from the FDA for Treating Relapsed/Refractory Multiple Myeloma or Relapsed/Refractory Primary Plasma Cell Leukemia
Dec 04, 2023
20
Nov 2023
CARsgen Announces Formation of its Clinical Advisory Board
Nov 20, 2023
15
Nov 2023
ASCO GI Preview | CARsgen to Present Results of CT041 at 2024 ASCO GI
Nov 15, 2023
20
Oct 2023
ASH Preview | CARsgen to Present Results of Zevor-cel at 2023 ASH Annual Meeting
Oct 20, 2023
12
Oct 2023
CARsgen's CAR-GPC3 T-cell Therapy for Advanced Hepatocellular Carcinoma: Two Patients Achieved over 7 Years of Disease-free Survival
Oct 12, 2023
21
Sep 2023
Two Cases of Pancreatic Cancer Treatment with CARsgen's CT041 Published in Journal of Hematology & Oncology
Sep 21, 2023
1
2
...
7